Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures.
European journal of neurology（2023）
摘要
ClinicalTrials.gov identifier: NCT04418765; EudraCT identifier: 2019-004497-25.
更多查看译文
关键词
efficacy,eptinezumab,migraine prevention,prior preventive treatment failure
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要